About
mRNA vaccine, therapies
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyChina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
117
By Phase
NA: 1EARLY_PHASE1: 1PHASE1/PHASE2: 1
By Status
NOT_YET_RECRUITING: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07143617Collaborator
Exploratory Clinical Study on the Safety of STR-P004
NANot yet recruiting
39 participants
Started: Sep 15, 2025 · Completed: Sep 14, 2026
NCT07003178Lead Sponsor
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
EARLY_PHASE1Not yet recruiting
30 participants
Started: Jun 30, 2025 · Completed: May 31, 2027
NCT06344975Lead Sponsor
A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults
PHASE1/PHASE2Not yet recruiting
48 participants
Started: May 31, 2024 · Completed: May 31, 2025
Locations (1)
Headquarters
Suzhou, China
Map
Loading map...